BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15962830)

  • 1. It's all about access.
    Stefanacci RG
    Manag Care; 2005 May; 14(5 Suppl):2. PubMed ID: 15962830
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspectives. Medicare overhaul: it's not just about drugs.
    Med Health; 2003 Jul; 57(26):7-8. PubMed ID: 12898810
    [No Abstract]   [Full Text] [Related]  

  • 3. Plan formularies fail to provide dual eligibles with access to critical meds.
    Med Health; 2006 Feb; 60(7):3, 7-8. PubMed ID: 16494129
    [No Abstract]   [Full Text] [Related]  

  • 4. It's that time of year again. Seniors can now switch Medicare drug plans.
    Andrews M
    US News World Rep; 2006 Nov; 141(20):68. PubMed ID: 17153489
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of the Medicare Part D benefit on medication management.
    Pezalla E
    Manag Care Interface; 2007 Jul; 20(7):13, 15. PubMed ID: 17849727
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical formularies: the right formula for cost and utilization?
    Austin B
    Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
    [No Abstract]   [Full Text] [Related]  

  • 7. The P&T Society.
    Bootman L
    Manag Care Interface; 2006 Feb; 19(2):13, 15. PubMed ID: 16583504
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacy benefit management as a quality safeguard.
    Giaquinta D
    Manag Care Interface; 2002 Mar; 15(3):54, 57. PubMed ID: 11925680
    [No Abstract]   [Full Text] [Related]  

  • 9. Medicare formulary model seen by many as too inclusive.
    Carroll J
    Manag Care; 2004 Nov; 13(11):10, 12. PubMed ID: 15595394
    [No Abstract]   [Full Text] [Related]  

  • 10. Hospitals given incentives to improve access to costly care.
    Health Care Strateg Manage; 2003 Dec; 21(12):11. PubMed ID: 14719371
    [No Abstract]   [Full Text] [Related]  

  • 11. Implications of Part D for mentally ill dual eligibles: a challenge for Medicare.
    Morden NE; Garrison LP
    Health Aff (Millwood); 2006; 25(2):491-500. PubMed ID: 16522603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory and legislative challenges facing managed care.
    Giaquinta D
    Manag Care Interface; 2000 Jul; 13(7):47-9. PubMed ID: 11183928
    [No Abstract]   [Full Text] [Related]  

  • 13. Translating dreams into reality. It's up to regulators, private sector to carry out best intentions of Congress.
    Tieman J
    Mod Healthc; 2003 Dec 22-29; 33(51):20-1, 26-7. PubMed ID: 14723079
    [No Abstract]   [Full Text] [Related]  

  • 14. ED drugs covered, but managed care unmoved.
    Manag Care; 2005 Mar; 14(3):64. PubMed ID: 15825613
    [No Abstract]   [Full Text] [Related]  

  • 15. Are formularies still relevant?
    Penna P
    Manag Care Interface; 2004 May; 17(5):45-6. PubMed ID: 15217165
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing Medicare prescription drug plans in four states: balancing cost and access.
    Heaton E; Carino T; Dix H
    Issue Brief (Commonw Fund); 2006 Aug; 22():1-14. PubMed ID: 16933399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing stakes and complex dynamics in the formulary process.
    Tadlock C
    Manag Care Interface; 2007 Mar; 20(3):12, 14. PubMed ID: 17458473
    [No Abstract]   [Full Text] [Related]  

  • 18. Proposal to regulate formularies draws sharp difference of opinion.
    Carlson B
    Manag Care; 2002 Feb; 11(2):34-8. PubMed ID: 11904911
    [No Abstract]   [Full Text] [Related]  

  • 19. A look ahead for managed care pharmacy in 2006.
    Giaquinta D
    Manag Care Interface; 2006 Feb; 19(2):39-40. PubMed ID: 16529079
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality is access in the Medicare prescription drug benefit--for now.
    Teagarden JR
    Manag Care Interface; 2006 Jul; 19(7):25, 27. PubMed ID: 16898342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.